10-K/A: Seer Inc. Files Amendment to 10-K to Include Part III Information

Seer, Inc. files an amendment to its 2024 annual report to include information required in Part III, related to directors, executive officers, and corporate governance.

Summary

• Seer, Inc. has filed Amendment No. 1 on Form 10-K/A to its original Form 10-K for the fiscal year ended December 31, 2024.
• The amendment includes information required to be disclosed in Part III of Form 10-K, which was previously omitted.
• The original report was filed on March 3, 2025, and this amendment does not modify or update any other disclosures or financial results from that report.
• The company's board of directors consists of seven members, with five deemed independent under Nasdaq listing standards.
• Key committees of the board include the audit committee, talent and compensation committee, corporate governance and nominating committee, and science and technology committee.
• The amendment details the composition, responsibilities, and meeting attendance of these committees.
• The document also outlines executive compensation, including base salaries, stock awards, option awards, and non-equity incentive plan compensation for named executive officers.
• The company's compensation philosophy aims to attract, retain, and reward top talent while aligning executive incentives with stockholder interests.
• The amendment includes information on security ownership of certain beneficial owners, management, and related stockholder matters.
• The company's equity compensation plans are detailed, including the number of securities to be issued upon exercise of outstanding options and the number of securities remaining available for future issuance.
• The document also describes certain relationships and related transactions, as well as the company's policies and procedures for related party transactions.
• Principal accounting fees and services provided by Deloitte & Touche LLP are disclosed for the fiscal years ended December 31, 2024 and 2023.

Sentiment

Score: 7

Explanation: The document is a standard regulatory filing, so the sentiment is neutral. However, the inclusion of Part III information provides a more complete picture of the company's governance and executive compensation, which is generally positive for investors.

Positives

• The company has a compensation recovery (clawback) policy in place.
• The company's insider trading policy prohibits hedging and pledging transactions.
• The audit committee pre-approves all audit and non-audit services performed by the independent registered public accounting firm.
• The company has a diverse board of directors with a mix of skills and experience.
• The company's compensation program is designed to align executive incentives with stockholder interests.

Risks

• The document does not explicitly mention any specific risks, but the company operates in the highly competitive and challenging life sciences industry.
• The company's future success depends on its ability to retain highly qualified and skilled executive leaders and employees.

Future Outlook

The document does not contain specific forward-looking statements beyond the general business strategy and goals.

Industry Context

The document mentions that the market for talented individuals in the life sciences industry is highly competitive and challenging for employers.

Comparison to Industry Standards

• The talent and compensation committee uses a peer group to provide a broad perspective on competitive pay levels and practices.
• For the 2024 peer group, the talent and compensation committee reviewed companies with respect to sector, stage of development and market capitalization.
• The peer group included companies such as Adaptive Biotechnologies Corp, Quanterix Corp, and Akoya Biosciences, Inc.

Stakeholder Impact

• The document provides stakeholders with information about the company's directors, executive officers, corporate governance, and executive compensation.
• This information is important for stakeholders to assess the company's leadership and management practices.

Key Dates

Keywords

executive compensation, corporate governance, board of directors, audit committee, directors, officers, Seer Inc., Form 10-K/A, amendment, financial reporting